| 证券代码：301098 | 证券简称：金埔园林 | 公告编号：2025-049 | | --- | --- | --- | | 债券代码：123198 | 债券简称：金埔转债 | | 金埔园林股份有限公司 关于 2024 年年度股东大会决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完 整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1.本次股东大会无否决议案的情形； 2.本次股东大会不涉及变更以往股东大会已通过的决议。 一、会议召开和出席情况 （一）会议召开情况 1.召开时间： （1）现场会议时间：2025年5月14日（星期三）14:30 （2）网络投票时间：2025年5月14日。其中： 通过深圳证券交易所交易系统进行网络投票的具体时间为：2025 年 5 月 14 日 9:15-9:25，9:30-11:30 和 13:00-15:00； 通过深圳证券交易所互联网投票系统投票的具体时间为：2025 年 5 月 14 日 9:15-15:00。 2.现场会议召开地点：南京市江宁区东山街道润麒路70号三楼会议室。 3.会议召集人：金埔园林股份有限公司董事会。 4.会议召开方式：现场 ...

| 证券代码：301098 | 证券简称：金埔园林 公告编号：2025-050 | | --- | --- | | 债券代码：123198 | 债券简称：金埔转债 | 2.现场会议召开地点：南京市江宁区东山街道润麒路70号三楼会议室 3.会议召集人：金埔园林股份有限公司董事会 4.会议召开方式：本次债券持有人会议采取现场与通讯表决相结合的方式召 开，投票采取记名方式表决 金埔园林股份有限公司 "金埔转债"2025 年第一次债券持有人会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完 整，没有虚假记载、误导性陈述或重大遗漏。 根据《金埔园林股份有限公司向不特定对象发行可转换公司债券募集说明书》 （以下简称"《募集说明书》"）《金埔园林股份有限公司可转换公司债券持有 人会议规则》（以下简称"《债券持有人会议规则》"）等有关规定，金埔园林 股份有限公司（以下简称"公司"）于2025年5月14日召开"金埔转债"2025年 第一次债券持有人会议。本次债券持有人会议相关情况如下： 一、会议召开和出席情况 （一）会议召开情况 1.会议届次："金埔转债"2025年第一次债券持有人会议 5.会议主持人：董事长 ...

Group 1: 华峰化学 - Company decided to terminate the acquisition of 100% equity in Zhejiang Huafeng Synthetic Resin Co., Ltd. and Zhejiang Huafeng Thermoplastic Polyurethane Co., Ltd. due to insufficient shareholder approval [1] - The decision was made based on prudence, as the proposal did not receive more than two-thirds of the valid voting rights at the shareholders' meeting [1] - Company will continue to promote related equity injection work and strictly fulfill asset injection commitments [1] Group 2: 中荣股份 - Actual controller and chairman Huang Huanran has been placed under residential surveillance by the police [2] - Other board members and senior management are performing their duties normally, and the board of directors is operating as usual [2] - Company specializes in the research, design, production, and sales of paper printing and packaging products [2] Group 3: 密尔克卫 - Three shareholders plan to reduce their holdings by a total of up to 2% of the company's shares through block trading [3] - The reduction includes 143.63 million shares, 97.65 million shares, and 75.03 million shares, representing 0.91%, 0.62%, and 0.47% of the total share capital respectively [3] - The reduction period is from June 6, 2025, to September 5, 2025, due to personal funding needs [3] Group 4: 舒泰神 - Subsidiary Jiangsu Beijietai Biotechnology Co., Ltd. has obtained a drug production license from the Jiangsu Provincial Drug Administration [4] - The license allows for the production of therapeutic biological products, specifically for registered declaration use [4] - The license is valid until May 7, 2030, and is not expected to have a significant impact on the company's current performance [4] Group 5: 捷顺科技 - Company won the bid for the "Chongqing Beautiful Sunshine Home and other public rental housing supporting parking space operation project" [5] - The project includes four public rental housing supporting parking lots with a total of 13,335 parking spaces [5] - The minimum guaranteed revenue for the project is quoted at 40.43 million yuan per year, with a total contract amount expected to exceed 100 million yuan [5] Group 6: 综艺股份 - Company signed an investment cooperation intention agreement to acquire control of Jiangsu Jilai Microelectronics Co., Ltd. through cash capital increase or share transfer [6] - Jilai Micro primarily engages in the research, production, and sales of power semiconductor chips and devices [6] - The transaction is expected to constitute a major asset restructuring [6] Group 7: 东山精密 - Subsidiary DSBJ PTE. LTD. plans to acquire 100% equity of French GMD Group for approximately 100 million euros (about 814 million yuan) [7] - The acquisition aims to advance the company's globalization strategy and enhance its market share in the automotive parts sector [7] - The company specializes in the research, production, and sales of electronic circuit products and precision components [7] Group 8: 诺诚健华 - Company reported a net profit of 17.97 million yuan for the first quarter of 2025, a significant turnaround from a loss of 142 million yuan in the same period last year [8] - The first quarter revenue reached 381 million yuan, representing a year-on-year growth of 129.92% [8] - The company focuses on the research, production, and commercialization of innovative drugs [8] Group 9: 凯美特气 - Shareholders plan to reduce their holdings by up to 3% of the company's shares through centralized bidding and/or block trading [9] - The total number of shares to be reduced is 20.86 million [9] - The reduction is due to personal funding needs [9] Group 10: 海创药业 - Controlling shareholder plans to reduce holdings by up to 2% of the company's shares through centralized bidding and block trading [10] - The total number of shares to be reduced is 1.98 million [10] - The reduction is due to personal funding needs [10] Group 11: 高争民爆 - Controlling shareholder plans to reduce holdings by up to 3% of the company's shares through centralized bidding and block trading [11] - The total number of shares to be reduced is 828,000 [11] - The reduction is due to the company's funding needs [11] Group 12: 金埔园林 - Two shareholders plan to reduce their holdings by a total of up to 1.91% of the company's shares [12] - The reductions include 183.93 million shares and 167.73 million shares [12] - The reasons for the reductions are asset optimization and personal funding needs [12] Group 13: 掌趣科技 - The largest shareholder plans to reduce holdings by up to 1% of the company's shares through centralized bidding or block trading [13] - The total number of shares to be reduced is 27.2 million [13] - The reduction is due to personal funding needs [13] Group 14: 美凯龙 - Company announced that its director and general manager has been placed under investigation and detention by the local supervisory committee [14] - Other board members and senior management are performing their duties normally, and daily operations are unaffected [14] - The company specializes in managing and operating self-operated and franchised shopping malls [14] Group 15: 新强联 - Major shareholder plans to reduce holdings by up to 1.89% of the company's shares through centralized bidding and block trading [15] - The total number of shares to be reduced is 717,490 [15] - The reduction is due to operational needs [15] Group 16: 日月明 - Shareholder plans to reduce holdings by up to 1% of the company's shares through centralized bidding [16] - The total number of shares to be reduced is 80,000 [16] - The reduction is due to personal funding needs [16] Group 17: 同有科技 - Major shareholder and vice president plan to reduce their holdings by up to 1.53% of the company's shares [17] - The total number of shares to be reduced is 730,850 [17] - The reduction is due to personal funding needs [17] Group 18: 爱尔眼科 - Subsidiary successfully acquired 60% equity and specific debt of Shenzhen Guangsheng Digital Technology Co., Ltd. for 650 million yuan [18] - The transaction constitutes a related party transaction [18] - The acquired asset will serve as long-term medical premises for the subsidiary [18]

Group 1 - Shareholders of Jinpu Garden plan to reduce their holdings by no more than 1.91% of the company's shares [1] - Shareholders of Xinqianglian plan to reduce their holdings by no more than 1.89% of the company's shares [1] - Hengbang shares received a regulatory letter for failing to disclose information in a timely manner [1] Group 2 - The Snowy Yong convertible bond and the Qianglian convertible bond will not be forcibly redeemed [1]

金埔园林（301098）公告，股东苏高新计划自公告披露之日起三个交易日后的第一个交易日起三个月内 以集中竞价方式减持不超过183.93万股，占公司总股本比例1%。股东金麟合伙计划自公告披露之日起 十五个交易日后的第一个交易日起三个月内以集中竞价方式减持不超过167.73万股，占公司总股本比例 0.91%。 ...

金埔园林股份有限公司 关于股东拟减持公司股份的预披露公告 公司股东苏州新区高新技术产业股份有限公司、镇江金麟企业管 理中心（有限合伙）保证向本公司提供的信息内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供 的信息一致。 特别提示： 持有金埔园林股份有限公司（以下简称"公司"）股份 5,139,813 股，占公司 总股本比例 2.79%的股东苏州新区高新技术产业股份有限公司（以下简称"苏高 新"）计划自本公告披露之日起三个交易日后的第一个交易日起三个月内以集中 竞价方式减持本公司股份不超过 1,839,313 股（不超过公司总股本比例 1%）。若 在减持计划实施期间内公司有送股、资本公积金转增股本、配股等除权除息事项， 上述数量将做相应调整。 | 证券代码：301098 | 证券简称：金埔园林 | 公告编号：2025-048 | | --- | --- | --- | | 债券代码：123198 | 债券简称：金埔转债 | | 二、本次减持计划的主要内容 （一）苏高新本次减持计划 1.减持原因：为盘活存量资产、优化产业结构、服务整体发展战略 2 ...

| 证券代码：301098 | 证券简称：金埔园林 公告编号：2025-047 | | --- | --- | | 债券代码：123198 | 债券简称：金埔转债 | 金埔园林股份有限公司 关于使用部分暂时闲置募集资金进行现金管理的进展公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完 整，没有虚假记载、误导性陈述或重大遗漏。 金埔园林股份有限公司（以下简称"公司"）于2025年4月18日召开第五届董 事会第二十二次会议和第五届监事会第十二次会议，分别审议通过了《关于使用 部分暂时闲置募集资金进行现金管理的议案》，同意公司在确保不影响募集资金 投资项目建设和正常生产经营的前提下，拟使用不超过50,000万元的暂时闲置募 集资金进行现金管理，用于购买满足安全性高、流动性好、期限不超过12个月的 短期投资理财产品，额度有效期限为董事会审议通过之日起12个月内。在前述额 度和有效期限内，资金可以循环滚动使用。 公司独立董事专门会议审议通过了上述事项，保荐机构也发表了明确同意的 意见。具体内容详见公司刊载于巨潮资讯网（www.cninfo.com.cn）上的《关于使 用部分暂时闲置募集资金进行现金管理的公告 ...

公园、花园等绿色空间为人们提供了放松、运动和社交的场所， 园林行业能满足人们对自然环境和户外活动场所的需求。（4） 生态旅游兴起：生态旅游在全球范围逐渐兴起，人们渴望亲近自 然。园林行业可结合地域特色与文化底蕴，打造生态旅游景点， 促进当地经济发展，提供就业机会。（5）技术创新推动：科技 进步促使园林行业融入现代技术，智能灌溉系统、数字设计工具 等为行业带来高效创新解决方案，有助于提高施工效率、改善资 源利用效率、增强环保意识。不过，园林行业也面临土地有限、 水资源短缺、环境污染、市场竞争激烈、劳动力成本上升等挑战。 但总体而言，在生态环保意识增强、技术不断进步等背景下，园 林行业前景向好。 2.高管您好，请问贵公司未来盈利增长的主要驱动因素有哪 些？谢谢。 答：在"双碳"目标的有力推动下，林业碳汇开发（CCER 重 启）与生态修复工程市场规模持续扩大。金埔园林凭借生态修复 与开发模式，高度契合政策导向，在这片市场蓝海中拥有巨大的 潜力与发展空间。城市更新与新型城镇化政策的推行，催生出每 年超万亿级别的市场，城市市政运维、环卫升级以及绿化管养的 需求极为旺盛。金埔园林所推行的城市环境综合服务模式，精准 匹配了 ...

证券简称：金埔园林 证券代码：301098 债券简称：金埔转债 债券代码：123198 金埔园林股份有限公司 向不特定对象发行可转换公司债券 受托管理事务报告 （2024 年度） 中国（上海）自由贸易试验区世纪大道1198号28层 2025 年 5 月 声 明 长江证券承销保荐有限公司（以下简称"长江保荐"或"保荐人"）编制本 报告的内容及信息均来源于发行人相关信息披露文件、金埔园林股份有限公司 （以下简称"金埔园林"、"发行人"或"公司"）提供的证明文件及第三方中 介机构出具的专业意见。长江保荐对报告中所包含的相关引述内容和信息未进行 独立验证，也不就该等引述内容和信息的真实性、准确性和完整性做出任何保证 或承担任何责任。 本报告不构成对投资者进行或不进行某项行为的推荐意见，投资者应对相关 事宜做出独立判断，而不应将本报告中的任何内容据以作为长江保荐所作的承诺 或声明。在任何情况下，投资者依据本报告所进行的任何作为或不作为，长江保 荐不承担任何责任。 金埔园林股份有限公司向不特定对象发行可转换公司债券受托管理事务报告（2024 年度） 一、债券概况 （一）发行人名称 可转债受托管理人： 6、票面利率：第一年 ...

长江证券承销保荐有限公司 | 保荐人名称：长江证券承销保荐有限公司 | 被保荐公司简称：金埔园林 | | --- | --- | | 保荐代表人姓名：苗健 | 联系电话：021-61118978 | | 保荐代表人姓名：张绍良 | 联系电话：021-61118978 | 一、保荐工作概述 | 项目 | 工作内容 | | --- | --- | | 1．公司信息披露审阅情况 | | | （1）是否及时审阅公司信息披露文件 | 是 | | （2）未及时审阅公司信息披露文件的次数 | 不适用 | | 2．督导公司建立健全并有效执行规章制度的情况 | | | （1）是否督导公司建立健全规章制度（包括但不限于 防止关联方占用公司资源的制度、募集资金管理制度、 | 是 | | 内控制度、内部审计制度、关联交易制度） | | | （2）公司是否有效执行相关规章制度 | 是 | | 3．募集资金监督情况 | | | （1）查询公司募集资金专户次数 | 2次 | | （2）公司募集资金项目进展是否与信息披露文件一致 | 是 | | 4．公司治理督导情况 | | | （1）列席公司股东会次数 | 1次 | | （2）列席公司董事 ...